[wooqa]

LTUS .0038

[wooqa]

LTUS .003

[wooqa]

LTUS .0006

[threewheeler]

LTUS SECURITY DETAILS fantastic float now
Share Structure
Market Cap Market Cap
24,250,640
08/03/2022
Authorized Shares
3,000,000,000
08/03/2022
Outstanding Shares
2,694,515,543 250m gone
08/03/2022
Restricted
2,681,123,970
08/03/2022
Unrestricted
13,391,573 250m gone from float as well
08/03/2022
Held at DTC
12,913,385
08/03/2022 Authorized Shares
3,000,000,000
11/28/2021
Outstanding Shares
2,944,515,543
11/28/2021
Restricted
2,681,123,970
11/28/2021
Unrestricted
263,391,573
11/28/2021

[threewheeler]

BUSINESS DESCRIPTION
Lotus Pharmaceuticals, Inc. is a development stage company actively seeking an acquisition partner in a 21st century emerging growth industry company.

[threewheeler]

LTUS SECURITY DETAILS
Share Structure
Market Cap Market Cap
68,459,986
11/26/2021
Authorized Shares
3,000,000,000
11/28/2021
Outstanding Shares
2,944,515,543
11/28/2021
Restricted
2,681,123,970
11/28/2021
Unrestricted
263,391,573
11/28/2021
Held at DTC
12,903,385
11/28/2021

[teampenny]

no clue. I am seeing $10-20k bids last week or so. 13M held at DTC, Pink Current. https://www.otcmarkets.com/stock/LTUS/security

[michaelstl]

Here we go again. Anyone know what's going on?

[Golden Cross]

LTUS Pink Current Today
https://www.otcmarkets.com/stock/LTUS/disclosure

[michaelstl]

They state in the quarterly report that this is the first time since 2014 that they are able to pay a dividend? I hope this is true!

https://www.lotuspharm.com/
Look at news and the quarterly report released today.

[michaelstl]

Earnings Released today

https://www.lotuspharm.com/Media/lotus-q121-earningsen-callsent.pdf

[TradeSmart.ai]

Great update today!!! Looking forward to news $LTUS https://www.otcmarkets.com/stock/LTUS/news/Lotus-Looking-at-Land-Development?id=301689

[TradeSmart.ai]

Very nice news didn’t see this until now $LTUS

[michaelstl]

Very Big News!!

https://finance.yahoo.com/news/lotus-pharmaceuticals-inc-current-otc-121200677.html

[michaelstl]

NEWSROOM
MONTHLY SALES REPORT FOR FEB 2021
POSTED ON 10.3.2021
Lotus today announced that its consolidated sales for February 2021 was NT$1,015,941 thousand, delivering a 95.4% growth over the same period last year. Its consolidated sales YTD’21 has increased by 75.8% YoY and reached NT$2.2 billion.

[michaelstl]

Up 125% in two days. Closed on the High!

[michaelstl]

Lotus Pharmaceutical filing Nashville TN USA office

https://marketexclusive.com/lotus-pharmaceuticals-inc-otcmktsltus-files-an-8-k-other-events/2020/02/

[TradeSmart.ai]

Very nice close today!!! What a move!!! $LTUS

[The Night Stalker]

https://www.stockscores.com/chart.asp?TickerSymbol=ltus&TimeRange=1825&Interval=m&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=200&Indicator1=AccDist&Indicator2=CMF&Indicator3=StochRSI&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen

[The Night Stalker]

wow

[michaelstl]

Selling at 1.45X Earnings?


Is it true that this is selling for this very very low PE?

[michaelstl]

Up 85%?

I have had this stock for years!!! It was up as much as 85% today?
Does anybody know what is going on?

[TradeSmart.ai]

Good close today $LTUS

[TradeSmart.ai]

Nice Green Day so far!!! $LTUS

[TradeSmart.ai]

Was a great day up until somebody dumped those 10K shares at the bid $LTUS

[TradeSmart.ai]

Looking good today good morning everyone $LTUS

[TradeSmart.ai]

Bought more $LTUS

[TradeSmart.ai]

Somebody is loading this one big time here. $LTUS

[TradeSmart.ai]

Thank you yes DM me $LTUS

[makinezmoney]

$LTUS : Got another banger for you..............


If you're interested in it.


I can tell you later.


But make sure you confirm you get before you alert the masses.



Will only send in PM but I've been on it.



GO $LTUS

[TradeSmart.ai]

It’s definitely an undiscovered gem one of the most beautiful $LTUS

[makinezmoney]

$LTUS: It is .............


Almost as beautiful as $NATUF



But thats just me.......... people see ROUGH......... I only see Diamonds.



One by one they unearth themselves and then people follow afterwards



GO $LTUS

[TradeSmart.ai]

What a beauty this one, added $LTUS

[cyanus]

Highest volume since 4/10/2012
Today volume 1,138,000 so far, had touched 2,000,000 shares back then at $0.179 price.
Hmmm :)

[makinezmoney]

$LTUS: Huge volume going here.......... lets go


Gonna run to $1



GO $LTUS

[TB87]

very high potential with an addition of a few backers

[ANTI-BAGHOLDER]

LTUS with a verified profile on OTC markets. Looks like updates are on the way.

[Sobek]

Anyone figure out who the new CEO is? All I come up with is a guy out of Nashville who is building up a rehab and just raised over a hundred grand this week in a charity concert. I reached out but no response yet.

[willlbone]

LaPus Pharma just popped like a zit.

[HDOGTX]

LTUS New officers posted on NEV SOS

https://esos.nv.gov/EntitySearch/BusinessFilingHistroy?businessid=505279

https://www.otcmarkets.com/stock/LTUS/profile

[swampboots]

LTUS would have to have the only drug which cures cancer for me to get my money to even.

[Steppenwolf$$$]

WILL MAKE LTUS MILLIONS YEARLY

[Steppenwolf$$$]

Hacho Hathcikian, Executive Vice President at Alvogen in the CEE regions, said: “The Lenalidomide launch is a major landmark for Alvogen in the CEE region as we are the first generic pharmaceutical company to launch the generic of Revlimid™ in our major markets. Patients now finally have access to an affordable and high-quality generic alternative of this leading oncology drug. Adding Lenalidomide to our portfolio also enhances our commitment to be one of the key oncology players in the CEE region.”

Revlimid™ is indicated for several hematological malignancies including multiple myeloma and is the biggest-selling oncology drug with approximately $9.8 billion sales globally.

Revlimid™ is a trademark of Celgene Corporation

[Steppenwolf$$$]

FEBRUARY 12, 2019
Alvogen
launches
the
first
generic
equivalent
to
Revlimid™
in
Europe
Alvogen today announced the launch of the first generic equivalent of Revlimid™ (lenalidomide) in several CEE markets including Romania, Croatia, Bulgaria and the Baltic states. The product will be marketed as 2.5, 5, 7.5, 10, 15, 20, 25mg hard capsules and is a fully generic and bioequivalent product to Revlimid™. Following the launch into multiple CEE countries, Alvogen’s Lenalidomide will also be launched in selected Asian countries in 2019.

Alvogen’s Lenalidomide has been developed fully in-house at Alvogen‘s subsidiary, Lotus Pharmaceuticals and is part of a comprehensive oncology pipeline

[Steppenwolf$$$]

https://alvogen.com/newsroom/alvogen-and-lotus-launch-the-first-generic-equivalent-to-revlimid

[Steppenwolf$$$]

$LTUS Alvogen’s Chairman & CEO Robert Wessman is the new Chairman of the Board at the publicly listed Lotus Pharmaceuticals in Taiwan, succeeding Andrew Lin. Lotus Pharmaceuticals, $5B COMPANY https://alvogen.com/newsroom

[Moving On]

I have been sitting on shares for a year or so and noticed some movement. What do you think this means.

[Steppenwolf$$$]

LTUS Alvogen’s Chairman & CEO Robert Wessman is the new Chairman of the Board at the publicly listed Lotus Pharmaceuticals in Taiwan, succeeding Andrew Lin. Lotus Pharmaceuticals, $5B COMPANY FEBRUARY 12, 2019
Alvogen
launches
the
first
generic
equivalent
to
Revlimid™
in
Europe
Alvogen today announced the launch of the first generic equivalent of Revlimid™ (lenalidomide) in several CEE markets including Romania, Croatia, Bulgaria and the Baltic states. The product will be marketed as 2.5, 5, 7.5, 10, 15, 20, 25mg hard capsules and is a fully generic and bioequivalent product to Revlimid™. Following the launch into multiple CEE countries, Alvogen’s Lenalidomide will also be launched in selected Asian countries in 2019.

Alvogen’s Lenalidomide has been developed fully in-house at Alvogen‘s subsidiary, Lotus Pharmaceuticals and is part of a comprehensive oncology pipeline.